• Protocols

• UW21051

  OPEN TO ACCRUAL

  Phase 1/2 Study LY3537982 in pts w/KRAS G12-C-Mutant Advanced Solid Tumors
  
  

• UW21125

  OPEN TO ACCRUAL

  Ph 1 Study of Denikitug alone and with Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors